Skip to main content

Articles

Page 279 of 284

  1. Medical oncologists continue to use performance status as a proxy for quality of life (QOL) measures, as completion of QOL instruments is perceived as time consuming, may measure aspects of QOL not affected by...

    Authors: Sandro J Martins, Nelson Ho, Sueli O Cavamura, Cecilia M Harada, Crystina A Yamamoto and Teresa Y Takagaki
    Citation: BMC Cancer 2005 5:72
  2. The clinical and pathological characteristics and the clinical course of patients with breast cancer and BRCA 1–2 mutation are poorly known.

    Authors: Andrea Veronesi, Clelia de Giacomi, Maria D Magri, Davide Lombardi, Martina Zanetti, Cristina Scuderi, Riccardo Dolcetti, Alessandra Viel, Diana Crivellari, Ettore Bidoli and Mauro Boiocchi
    Citation: BMC Cancer 2005 5:70
  3. Cervical carcinoma (CC) is one of the most common cancers among women worldwide and the first cause of death among the Mexican female population. CC progression shows a continuum of neoplastic transitions unti...

    Authors: Guelaguetza Vazquez-Ortiz, Patricia Pina-Sanchez, Karla Vazquez, Alfonso Duenas, Lucia Taja, Patricia Mendoza, José A Garcia and Mauricio Salcedo
    Citation: BMC Cancer 2005 5:68

    The Erratum to this article has been published in BMC Cancer 2005 5:164

  4. APC (Adenomatous polyposis coli) plays an important role in the pathogenesis of both familial and sporadic colorectal cancer. Patients carrying germline APC mutations develop multiple colonic adenomas at younger...

    Authors: Sima Salahshor, Jason Goncalves, Runjan Chetty, Steven Gallinger and James R Woodgett
    Citation: BMC Cancer 2005 5:66
  5. It has been shown that free DNA circulates in serum plasma of patients with cancer and that at least part is present in the form of oligo- and monucleosomes, a marker of cell death. Preliminary data has shown ...

    Authors: Catalina Trejo-Becerril, Luis F Oñate-Ocaña, Lucía Taja-Chayeb, América Vanoye-Carlo, Lucely Cetina and Alfonso Duenas-Gonzalez
    Citation: BMC Cancer 2005 5:65
  6. The putative tumor suppressor WWOX gene spans the common chromosomal fragile site 16D (FRA16D) at chromosome area 16q23.3-24.1. This region is a frequent target for loss of heterozygosity and chromosomal rearrang...

    Authors: María I Nunez, Daniel G Rosen, John H Ludes-Meyers, Martín C Abba, Hyunsuk Kil, Robert Page, Andres JP Klein-Szanto, Andrew K Godwin, Jinsong Liu, Gordon B Mills and C Marcelo Aldaz
    Citation: BMC Cancer 2005 5:64
  7. P-cadherin (P-cad) is a transmembrane molecule involved in the cell-cell adhesion and similar to E-cadherin (E-cad), but less investigated in oncology, especially in in vivo studies. Aims of the present study wer...

    Authors: Lorenzo Lo Muzio, Giuseppina Campisi, Antonio Farina, Corrado Rubini, Giuseppe Pannone, Rosario Serpico, Gregorio Laino, Alfredo De Lillo and Francesco Carinci
    Citation: BMC Cancer 2005 5:63
  8. Epidermal growth factor receptor (EGFR) represents a major target for current radiosensitizing strategies. We wished to ascertain whether a correlation exists between the expression of EGFR and treatment outco...

    Authors: David Azria, Frederic Bibeau, Nicolas Barbier, Abderrahim Zouhair, Claire Lemanski, Philippe Rouanet, Marc Ychou, Pierre Senesse, Mahmut Ozsahin, André Pèlegrin, Jean-Bernard Dubois and Simon Thèzenas
    Citation: BMC Cancer 2005 5:62
  9. Patients with advanced gallbladder and biliary tract carcinoma face a dismal prognosis, as no effective palliative chemotherapy exists. The antitumor effect of gemcitabine is schedule-dependent rather than dos...

    Authors: Stefan von Delius, Christian Lersch, Ewert Schulte-Frohlinde, Martina Mayr, Roland M Schmid and Florian Eckel
    Citation: BMC Cancer 2005 5:61
  10. Ex-vivo chemosensitivity tests that measure cell death induction may predict treatment outcome and, therefore, represent a powerful instrument for clinical decision making in cancer therapy. Such tests are, ho...

    Authors: Peter Staib, Jan Tiehen, Timo Strunk and Timo Schinköthe
    Citation: BMC Cancer 2005 5:60
  11. Acute RT-induced damage to the lung is characterized by inflammatory changes, which proceed to the development of fibrotic lesions in the late phase of injury. Ultimately, complete structural ablation will ens...

    Authors: Zahid N Rabbani, Mitchell S Anscher, Rodney J Folz, Emerald Archer, Hong Huang, Liguang Chen, Maria L Golson, Thaddeus S Samulski, Mark W Dewhirst and Zeljko Vujaskovic
    Citation: BMC Cancer 2005 5:59
  12. Downstream of Ras, the serine/threonine kinase B-raf has been reported to be mutated, among other carcinomas, in a substantial subset of primary melanomas with a preponderance of mutations within the kinase do...

    Authors: Martin Deichmann, Marianne Thome, Axel Benner, Martin Kirschner, Judith Hassanzadeh and Hjalmar Kurzen
    Citation: BMC Cancer 2005 5:58
  13. Biallelic von Hippel-Lindau (VHL) gene defects, a rate-limiting event in the carcinogenesis, occur in approximately 75% of sporadic clear-cell Renal Cell Carcinoma (RCC). We studied the VHL mutation status in a l...

    Authors: Kjeld P van Houwelingen, Boukje AC van Dijk, Christina A Hulsbergen-van de Kaa, Leo J Schouten, Hanneke JM Gorissen, Jack A Schalken, Piet A van den Brandt and Egbert Oosterwijk
    Citation: BMC Cancer 2005 5:57
  14. Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in patients with peritoneal carcinomatosis of colorectal origin. Animal models are important in the evaluation of n...

    Authors: Joerg OW Pelz, Joerg Doerfer, Werner Hohenberger and Thomas Meyer
    Citation: BMC Cancer 2005 5:56
  15. Hypofractionated stereotactic radiotherapy (HFSRT) is one salvage treatment option in previously irradiated patients with recurrent malignant glioma. We analyzed the results of HFSRT and prognostic factors in ...

    Authors: Dirk Vordermark, Oliver Kölbl, Klemens Ruprecht, Giles H Vince, Klaus Bratengeier and Michael Flentje
    Citation: BMC Cancer 2005 5:55
  16. Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) selectively induces apoptosis in cancer cells but not in normal cells. Despite this promising feature, TRAIL resistance observed in cancer ...

    Authors: Ahter D Sanlioglu, Ercument Dirice, Cigdem Aydin, Nuray Erin, Sadi Koksoy and Salih Sanlioglu
    Citation: BMC Cancer 2005 5:54
  17. Sarcomas are one of the most refractory diseases among malignant tumors. More effective therapies based on an increased understanding of the molecular biology of sarcomas are needed as current forms of therapy...

    Authors: Iwao Mikami, Liang You, Biao He, Zhidong Xu, Sonny Batra, Amie Y Lee, Julien Mazieres, Noemi Reguart, Kazutsugu Uematsu, Kiyoshi Koizumi and David M Jablons
    Citation: BMC Cancer 2005 5:53
  18. Over the last two decades time trends in incidence rates of colorectal cancer, changes in the proportions of stage at diagnosis and changes in the anatomic sub-site distribution of colon cancers have been repo...

    Authors: René Scheiden, Paul Pescatore, Yolande Wagener, Nelly Kieffer and Catherine Capesius
    Citation: BMC Cancer 2005 5:52
  19. Therapeutic gene transfer affords a clinically feasible and safe approach to cancer treatment but a more effective modality is needed to improve clinical outcomes. Combined transfer of therapeutic genes with d...

    Authors: Kyung-Sun Hwang, Won-Kyung Cho, Jinsang Yoo, Hwan-Jung Yun, Samyong Kim and Dong-Soo Im
    Citation: BMC Cancer 2005 5:51
  20. The present commonly used five-year survival rates are not adequate to represent the statistical cure. In the present study, we established the minimum number of years required for follow-up to estimate statis...

    Authors: Patricia Tai, Edward Yu, Gábor Cserni, Georges Vlastos, Melanie Royce, Ian Kunkler and Vincent Vinh-Hung
    Citation: BMC Cancer 2005 5:48
  21. Tumor-associated antigens are appreciated as diagnostic markers, but they have also prompted tremendous efforts to develop tumor-specific immunotherapy. A previously cloned tumor-associated antigen, EBAG9, was...

    Authors: Tatiana A Reimer, Ioannis Anagnostopoulos, Bettina Erdmann, Insa Lehmann, Harald Stein, Peter Daniel, Bernd Dörken and Armin Rehm
    Citation: BMC Cancer 2005 5:47
  22. Typical high throughput microarrays experiments compare gene expression across two specimen classes – an experimental class and baseline (or comparison) class. The choice of specimen classes is a major factor ...

    Authors: Uma R Chandran, Rajiv Dhir, Changqing Ma, George Michalopoulos, Michael Becich and John Gilbertson
    Citation: BMC Cancer 2005 5:45
  23. The antihypertensive compound hydralazine is a known demethylating agent. This phase I study evaluated the tolerability and its effects upon DNA methylation and gene reactivation in patients with untreated cer...

    Authors: Pilar Zambrano, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucely Cetina, Alma Revilla-Vazquez, Lucía Taja-Chayeb, Alma Chavez-Blanco, Enrique Angeles, Gustavo Cabrera, Karina Sandoval, Catalina Trejo-Becerril, Jose Chanona-Vilchis and Alfonso Duenas-González
    Citation: BMC Cancer 2005 5:44
  24. The FANCA gene is one of the genes in which mutations lead to Fanconi anaemia, a rare autosomal recessive disorder characterised by congenital abnormalities, bone marrow failure, and predisposition to malignancy....

    Authors: Ella Thompson, Rebecca L Dragovic, Sally-Anne Stephenson, Diana M Eccles, Ian G Campbell and Alexander Dobrovic
    Citation: BMC Cancer 2005 5:43
  25. Several parameters of the tumor microenvironment, such as hypoxia, inflammation and angiogenesis, play a critical role in tumor aggressiveness and treatment response. A major question remains if these markers ...

    Authors: Harlinde De Schutter, Willy Landuyt, Erik Verbeken, Laurence Goethals, Robert Hermans and Sandra Nuyts
    Citation: BMC Cancer 2005 5:42
  26. Carbonic anhydrase (CA) isozymes may have an important role in cancer development. Some isozymes control pH homeostasis in tumors that appears to modulate the behaviour of cancer cells. CA XIII is the newest m...

    Authors: Laura Kummola, Jonna M Hämäläinen, Jyrki Kivelä, Antti J Kivelä, Juha Saarnio, Tuomo Karttunen and Seppo Parkkila
    Citation: BMC Cancer 2005 5:41
  27. Familial Adenomatous Polyposis (FAP) is caused by germline mutations in the APC (Adenomatous Polyposis Coli) gene. The vast majority of APC mutations are point mutations or small insertions / deletions which lead...

    Authors: Markos Mihalatos, Angela Apessos, Hans Dauwerse, Voula Velissariou, Aristidis Psychias, Alexander Koliopanos, Konstantinos Petropoulos, John K Triantafillidis, Ioannis Danielidis, George Fountzilas, Niki J Agnantis and Georgios Nasioulas
    Citation: BMC Cancer 2005 5:40
  28. Aberrant expression of myeloid antigens (MyAgs) on acute lymphoblastic leukemia (ALL) cells is a well-documented phenomenon, although its regulating mechanisms are unclear. MyAgs in ALL are interpreted e.g. as...

    Authors: Tomas Kalina, Martina Vaskova, Ester Mejstrikova, Jozef Madzo, Jan Trka, Jan Stary and Ondrej Hrusak
    Citation: BMC Cancer 2005 5:38
  29. After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-yea...

    Authors: HP Knaebel, A Märten, J Schmidt, K Hoffmann, C Seiler, K Lindel, H Schmitz-Winnenthal, S Fritz, T Herrmann, H Goldschmidt, R Krempien, U Mansmann, J Debus, V Diehl and MW Büchler
    Citation: BMC Cancer 2005 5:37
  30. The role of genes involved in the control of progression from the G1 to the S phase of the cell cycle in melanoma tumors in not fully known. The aim of our study was to analyse mutations in TP53, CDKN1A, CDKN2...

    Authors: José Luis Soto, Carmen M Cabrera, Salvio Serrano and Miguel Ángel López-Nevot
    Citation: BMC Cancer 2005 5:36
  31. There appear to be geographical differences in decisions to perform mastectomy or breast conserving surgery for early-stage breast cancer. This study was carried out to evaluate general surgeons' preferences i...

    Authors: Massoome Najafi, Mandana Ebrahimi, Ahmad Kaviani, Esmat Hashemi and Ali Montazeri
    Citation: BMC Cancer 2005 5:35
  32. There are very few studies that report the incidence of acute leukemias in children in Latin America. This work assesses the incidence of acute leukemias, between 1996 and 2000, in children from 0–14 years old...

    Authors: Juan Manuel Mejía-Aranguré, Miguel Bonilla, Rodolpho Lorenzana, Servando Juárez-Ocaña, Gladys de Reyes, María Luisa Pérez-Saldivar, Guadalupe González-Miranda, Roberto Bernáldez-Ríos, Antonio Ortiz-Fernández, Manuel Ortega-Alvarez, María del Carmen Martínez-García and Arturo Fajardo-Gutiérrez
    Citation: BMC Cancer 2005 5:33
  33. HSV-tk/ ganciclovir (GCV) gene therapy has been extensively studied in the setting of brain tumors and largely relies on the bystander effect. Large studies have however failed to demonstrate any significant b...

    Authors: Pierre A Robe, Minh Nguyen-Khac, Olivier Jolois, Bernard Rogister, Marie-Paule Merville and Vincent Bours
    Citation: BMC Cancer 2005 5:32
  34. There is controversy about the effect of the timing of intraperitoneal administration of chemotherapeutic agents on the healing of intestinal anastomosis. We have investigated the effect on intestinal wound he...

    Authors: Ali Uzunkoy, Cengiz Bolukbas, Mehmet Horoz, Fusun F Bolukbas and Abdurrahim Kocyigit
    Citation: BMC Cancer 2005 5:31
  35. Few data are available on compliance and safety of adjuvant chemotherapy when indicated in elderly breast cancer patients; CMF (cyclophosphamide, methotrexate, fluorouracil) can be reasonably considered the mo...

    Authors: Ermelinda De Maio, Adriano Gravina, Carmen Pacilio, Gerardo Amabile, Vincenzo Labonia, Gabriella Landi, Francesco Nuzzo, Emanuela Rossi, Giuseppe D'Aiuto, Immacolata Capasso, Massimo Rinaldo, Brunello Morrica, Massimo Elmo, Massimo Di Maio, Francesco Perrone and Andrea de Matteis
    Citation: BMC Cancer 2005 5:30
  36. Activation of the phosphatidylinositol 3-kinase (PI3K) through mutational inactivation of PTEN tumour suppressor gene is common in diverse cancer types, but rarely reported in gastric cancer. Recently, mutations ...

    Authors: Vivian Sze Wing Li, Chi Wai Wong, Tsun Leung Chan, Agnes Sze Wah Chan, Wei Zhao, Kent-Man Chu, Samuel So, Xin Chen, Siu Tsan Yuen and Suet Yi Leung
    Citation: BMC Cancer 2005 5:29
  37. Sentinel lymph node (SLN) biopsy is an effective tool for axillary staging in patients with invasive breast cancer. This procedure has been recently proposed as part of the treatment for patients with ductal c...

    Authors: Giorgio Zavagno, Paolo Carcoforo, Renato Marconato, Zeno Franchini, Giuliano Scalco, Paolo Burelli, Paolo Pietrarota, Mario Lise, Roberto Mencarelli, Giovanni Capitanio, Andrea Ballarin, Maria Elena Pierobon, Giorgia Marconato and Donato Nitti
    Citation: BMC Cancer 2005 5:28
  38. The advent of prostate specific antigen (PSA) testing in the United States of America (USA) has led to a dramatic increase in the incidence of prostate cancer in the United States as well as the number of men ...

    Authors: Richard M Hoffman, S Noell Stone, David Espey and Arnold L Potosky
    Citation: BMC Cancer 2005 5:27
  39. Epidemiological studies have shown that individuals who regularly consume NSAIDs have lower rates of mortality associated with colorectal cancer. Because COX-2 inhibitors prevent tumor growth through some mech...

    Authors: Hirotoshi Kobayashi, Hiroyuki Uetake, Tetsuro Higuchi, Masayuki Enomoto and Kenichi Sugihara
    Citation: BMC Cancer 2005 5:26
  40. Cancer of unknown primary remains a mallignancy of elusive biology and grim prognosis that lacks effective therapeutic options. We investigated angiogenesis in cancer of unknown primary to expand our knowledge...

    Authors: Vasilis Karavasilis, Vasiliki Malamou-Mitsi, Evangelos Briasoulis, Elena Tsanou, Evangelia Kitsou, Haralambos Kalofonos, George Fountzilas, Theodore Fotsis and Nicholas Pavlidis
    Citation: BMC Cancer 2005 5:25
  41. To identify early symptoms of familial adenomatous polyposis with a view to improve early diagnosis and treatment. Diagnosis on the basis of genetic testing is usually limited to where there is a known family ...

    Authors: Roland S Croner, Wolfgang M Brueckl, Bertram Reingruber, Werner Hohenberger and Klaus Guenther
    Citation: BMC Cancer 2005 5:24
  42. Upper urothelial cancer (UUC), i.e. transitional cell carcinomas of the renal pelvis and the ureter, occur at an increased frequency in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Defectiv...

    Authors: Kajsa M Ericson, Anna P Isinger, Björn L Isfoss and Mef C Nilbert
    Citation: BMC Cancer 2005 5:23

Featured videos

View featured videos from across the BMC-series journals